Black Deal 12 months of Premium for €49.99 instead of €74.99 12 months €49.99 instead of €74.99 until Sun, Dec 13
Get the deal

toboust - FACEIT level 10, 2,108 ELO

Finland
On FACEIT since 2019 263 matches tracked 17 matches in 30 days
ELO ▼ 75
2,108
30-day peak: 2,183
Rank EU
#191,643
Finland #4,802 in Finland
Last updated:

toboust at a glance

Level 10 2,108 ELO best map Mirage (55%)
2,001-2,249 ELO

Last 20 matches compared with 2,996 players in this group: K/R and ADR above average, win rate below average.

RatingCalculated with the HLTV Rating 1.0 formula from kills, deaths and multi-kills per round. 1.00 is an average match.
better than 56%
1.05
SpreadHow much the rating swings from match to match. The smaller, the more consistent. ±0.38 ConsistencyShare of matches with a rating of 0.90 or higher. 70%
K/R
0.76
better than 60% of players
2,001-2,249 ELO avg: 0.74
Last 12 months
ADR
83.9
better than 65% of players
2,001-2,249 ELO avg: 80.7
Last 12 months
Win rate
35%
better than 8% of players
2,001-2,249 ELO avg: 50%
Last 12 months

Facts

328 ELO Next goal That is 13 to 14 wins.
3 W · 2 L Best day +74 ELO · Oct 14, 2026
Mirage Favorite map 95 of 263 matches
Mirage 55% Map pool tip weakest: Nuke 33%
10 knife kills Rare kills last 90 days
On Wednesdays Best time 59% win rate vs. 48%
FormMapsTiming

328 ELO away from the recorded peak (2,436). That is 13 to 14 wins. 3:2 on Oct 14, 2026 (+74 ELO, last 90 days). Most played: Mirage (95 of 263 matches). Strongest map: Mirage (55% win rate, 95 matches). Weakest: Nuke (33%, 24 matches). 10 knife kills (last 90 days). Best results on Wednesdays: 59% win rate vs. 48% overall (49 matches).

About toboust

toboust plays CS2 on FACEIT level 10 with 2,108 ELO. The stats cover 263 matches. toboust plays Mirage the most and wins it the most: 55% win rate in 95 matches. Biggest strength: Rounds with first kill at 13%, better than 84% of level 10 · 2,001-2,249 ELO players. Last 20 matches: 7 wins, 13 losses, -94 ELO. toboust does best on Wednesdays: 59% win rate in 49 matches.